Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis

Blood Cancer J. 2018 May 24;8(5):46. doi: 10.1038/s41408-018-0086-3.

¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. [email protected].
² Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
³ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
⁴ Centro de Investigación Médica Aplicada, Clinica Universidad de Navarra, IDISNA, Pamplona, Spain.

No abstract available

Publication types